Medical Market Report

Global Clinical Trial (CTMS) Market By Type (Cloud-based (SaaS) CTMS, Licensed Enterprise (On-premise) CTMS, and Web-based (Hosted) CTMS), By Application (Clinical Research Organizations (CROs), Medical Device Firms, Pharmaceutical & Biotechnology Firms, and Other End Users), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138351
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Clinical Trial (CTMS) Market is estimated to be valued US$ XX.X million in 2019. The report on Clinical Trial (CTMS) Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global clinical trial (ctms) market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Clinical Trial (CTMS) Market Scope:

    By type, the market is segmented into Cloud-based (SaaS) CTMS, Licensed Enterprise (On-premise) CTMS, and Web-based (Hosted) CTMS. By Application, the market is divided into Clinical Research Organizations (CROs), Medical Device Firms, Pharmaceutical & Biotechnology Firms, and Other End Users.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include ArisGlobal, Bioclinica, Bio-Optronics, Datatrak International, DSG(Document Solutions Group), eClinForce, Forte Research Systems, Medidata Solutions, Mednet Solutions, Merge Healthcareorporated (IBM), Oracle Corporation, Parexel International, and Veeva Systems.

    Key Market Segments

    Type

    Cloud-based (SaaS) CTMS

    Licensed Enterprise (On-premise) CTMS

    Web-based (Hosted) CTMS

    Application

    Clinical Research Organizations (CROs)

    Medical Device Firms

    Pharmaceutical & Biotechnology Firms

    Other End Users

    Key Market Players included in the report:

    ArisGlobal

    Bioclinica

    Bio-Optronics

    Datatrak International

    DSG(Document Solutions Group)

    eClinForce

    Forte Research Systems

    Medidata Solutions

    Mednet Solutions

    Merge Healthcareorporated (IBM)

    Oracle Corporation

    Parexel International

    Veeva Systems

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Clinical Trial (CTMS) Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Clinical Trial (CTMS) Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Clinical Trial (CTMS) Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Clinical Trial (CTMS) Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Clinical Trial (CTMS) Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Clinical Trial (CTMS) Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Clinical Trial (CTMS) sub-markets, depending on key regions (various vital states).
    To analyze Clinical Trial (CTMS) Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Clinical Trial (CTMS) Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Clinical Trial (CTMS) Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Clinical Trial (CTMS) Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Clinical Trial (CTMS) Market Overview
    

    3.1. Clinical Trial (CTMS) Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Clinical Trial (CTMS) Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Clinical Trial (CTMS) Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Cloud-based (SaaS) CTMS
    

      4.4. Licensed Enterprise (On-premise) CTMS
    

      4.5. Web-based (Hosted) CTMS
    

    5. Global Clinical Trial (CTMS) Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Clinical Trial (CTMS) Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Clinical Research Organizations (CROs)
    

      5.4. Medical Device Firms
    

      5.5. Pharmaceutical & Biotechnology Firms
    

      5.6. Other End Users
    

    6. Global Clinical Trial (CTMS) Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Clinical Trial (CTMS) Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Clinical Trial (CTMS) Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Clinical Trial (CTMS) Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Clinical Trial (CTMS) Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Clinical Trial (CTMS) Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Clinical Trial (CTMS) Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. ArisGlobal
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Bioclinica
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Bio-Optronics
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Datatrak International
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. DSG(Document Solutions Group)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. eClinForce
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Forte Research Systems
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Medidata Solutions
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Mednet Solutions
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Merge Healthcareorporated (IBM)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. Oracle Corporation
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. Parexel International
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

      7.15. Veeva Systems
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.